Agricultural Inputs
Compare Stocks
2 / 10Stock Comparison
CTVA vs FMC
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Inputs
CTVA vs FMC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Agricultural Inputs | Agricultural Inputs |
| Market Cap | $54.89B | $1.85B |
| Revenue (TTM) | $17.89B | $3.43B |
| Net Income (TTM) | $1.16B | $-2.50B |
| Gross Margin | 33.5% | 35.3% |
| Operating Margin | 13.8% | -59.5% |
| Forward P/E | 22.3x | 8.4x |
| Total Debt | $2.58B | $4.20B |
| Cash & Equiv. | $4.52B | $585M |
CTVA vs FMC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Corteva, Inc. (CTVA) | 100 | 299.4 | +199.4% |
| FMC Corporation (FMC) | 100 | 15.0 | -85.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CTVA vs FMC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CTVA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 2.9%, EPS growth 23.1%, 3Y rev CAGR -0.1%
- 195.9% 10Y total return vs FMC's -26.2%
- Lower volatility, beta 0.29, Low D/E 10.6%, current ratio 1.43x
FMC is the clearest fit if your priority is income & stability.
- Dividend streak 7 yrs, beta 1.63, yield 15.7%
- Lower P/E (8.4x vs 22.3x)
- 15.7% yield, 7-year raise streak, vs CTVA's 0.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.9% revenue growth vs FMC's -18.3% | |
| Value | Lower P/E (8.4x vs 22.3x) | |
| Quality / Margins | 6.5% margin vs FMC's -72.9% | |
| Stability / Safety | Beta 0.29 vs FMC's 1.63, lower leverage | |
| Dividends | 15.7% yield, 7-year raise streak, vs CTVA's 0.9% | |
| Momentum (1Y) | +32.1% vs FMC's -54.8% | |
| Efficiency (ROA) | 2.7% ROA vs FMC's -23.0%, ROIC 8.5% vs -21.2% |
CTVA vs FMC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CTVA vs FMC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CTVA leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CTVA is the larger business by revenue, generating $17.9B annually — 5.2x FMC's $3.4B. CTVA is the more profitable business, keeping 6.5% of every revenue dollar as net income compared to FMC's -72.9%. On growth, CTVA holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $17.9B | $3.4B |
| EBITDAEarnings before interest/tax | $3.4B | -$1.9B |
| Net IncomeAfter-tax profit | $1.2B | -$2.5B |
| Free Cash FlowCash after capex | $2.1B | -$91M |
| Gross MarginGross profit ÷ Revenue | +33.5% | +35.3% |
| Operating MarginEBIT ÷ Revenue | +13.8% | -59.5% |
| Net MarginNet income ÷ Revenue | +6.5% | -72.9% |
| FCF MarginFCF ÷ Revenue | +11.5% | -2.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.0% | -4.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +12.6% | -17.8% |
Valuation Metrics
FMC leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $54.9B | $1.8B |
| Enterprise ValueMkt cap + debt − cash | $52.9B | $5.5B |
| Trailing P/EPrice ÷ TTM EPS | 51.10x | -0.83x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.30x | 8.37x |
| PEG RatioP/E ÷ EPS growth rate | 4.28x | — |
| EV / EBITDAEnterprise value multiple | 13.85x | — |
| Price / SalesMarket cap ÷ Revenue | 3.15x | 0.53x |
| Price / BookPrice ÷ Book value/share | 2.26x | 0.88x |
| Price / FCFMarket cap ÷ FCF | 19.50x | — |
Profitability & Efficiency
CTVA leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
CTVA delivers a 4.6% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-82 for FMC. CTVA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to FMC's 2.00x. On the Piotroski fundamental quality scale (0–9), CTVA scores 6/9 vs FMC's 2/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +4.6% | -82.3% |
| ROA (TTM)Return on assets | +2.7% | -23.0% |
| ROICReturn on invested capital | +8.5% | -21.2% |
| ROCEReturn on capital employed | +8.6% | -25.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 2 |
| Debt / EquityFinancial leverage | 0.11x | 2.00x |
| Net DebtTotal debt minus cash | -$1.9B | $3.6B |
| Cash & Equiv.Liquid assets | $4.5B | $585M |
| Total DebtShort + long-term debt | $2.6B | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | 5.82x | -0.24x |
Total Returns (Dividends Reinvested)
CTVA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTVA five years ago would be worth $17,540 today (with dividends reinvested), compared to $2,128 for FMC. Over the past 12 months, CTVA leads with a +32.1% total return vs FMC's -54.8%. The 3-year compound annual growth rate (CAGR) favors CTVA at 13.3% vs FMC's -43.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +20.9% | +3.7% |
| 1-Year ReturnPast 12 months | +32.1% | -54.8% |
| 3-Year ReturnCumulative with dividends | +45.5% | -81.5% |
| 5-Year ReturnCumulative with dividends | +75.4% | -78.7% |
| 10-Year ReturnCumulative with dividends | +195.9% | -26.2% |
| CAGR (3Y)Annualised 3-year return | +13.3% | -43.0% |
Risk & Volatility
CTVA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CTVA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than FMC's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTVA currently trades 95.5% from its 52-week high vs FMC's 33.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.29x | 1.63x |
| 52-Week HighHighest price in past year | $85.63 | $44.78 |
| 52-Week LowLowest price in past year | $60.54 | $12.17 |
| % of 52W HighCurrent price vs 52-week peak | +95.5% | +33.0% |
| RSI (14)Momentum oscillator 0–100 | 64.4 | 43.9 |
| Avg Volume (50D)Average daily shares traded | 3.4M | 3.2M |
Analyst Outlook
FMC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates CTVA as "Buy" and FMC as "Hold". Consensus price targets imply 7.8% upside for CTVA (target: $88) vs 5.3% for FMC (target: $16). For income investors, FMC offers the higher dividend yield at 15.73% vs CTVA's 0.86%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $88.17 | $15.58 |
| # AnalystsCovering analysts | 37 | 42 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +15.7% |
| Dividend StreakConsecutive years of raises | 5 | 7 |
| Dividend / ShareAnnual DPS | $0.71 | $2.33 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | +0.1% |
CTVA leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FMC leads in 2 (Valuation Metrics, Analyst Outlook).
CTVA vs FMC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CTVA or FMC a better buy right now?
For growth investors, Corteva, Inc.
(CTVA) is the stronger pick with 2. 9% revenue growth year-over-year, versus -18. 3% for FMC Corporation (FMC). Corteva, Inc. (CTVA) offers the better valuation at 51. 1x trailing P/E (22. 3x forward), making it the more compelling value choice. Analysts rate Corteva, Inc. (CTVA) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CTVA or FMC?
On forward P/E, FMC Corporation is actually cheaper at 8.
4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CTVA or FMC?
Over the past 5 years, Corteva, Inc.
(CTVA) delivered a total return of +75. 4%, compared to -78. 7% for FMC Corporation (FMC). Over 10 years, the gap is even starker: CTVA returned +195. 9% versus FMC's -26. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CTVA or FMC?
By beta (market sensitivity over 5 years), Corteva, Inc.
(CTVA) is the lower-risk stock at 0. 29β versus FMC Corporation's 1. 63β — meaning FMC is approximately 454% more volatile than CTVA relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 2% for FMC Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CTVA or FMC?
By revenue growth (latest reported year), Corteva, Inc.
(CTVA) is pulling ahead at 2. 9% versus -18. 3% for FMC Corporation (FMC). On earnings-per-share growth, the picture is similar: Corteva, Inc. grew EPS 23. 1% year-over-year, compared to -757. 4% for FMC Corporation. Over a 3-year CAGR, CTVA leads at -0. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CTVA or FMC?
Corteva, Inc.
(CTVA) is the more profitable company, earning 6. 3% net margin versus -64. 6% for FMC Corporation — meaning it keeps 6. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTVA leads at 15. 1% versus -54. 4% for FMC. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CTVA or FMC more undervalued right now?
On forward earnings alone, FMC Corporation (FMC) trades at 8.
4x forward P/E versus 22. 3x for Corteva, Inc. — 13. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTVA: 7. 8% to $88. 17.
08Which pays a better dividend — CTVA or FMC?
All stocks in this comparison pay dividends.
FMC Corporation (FMC) offers the highest yield at 15. 7%, versus 0. 9% for Corteva, Inc. (CTVA).
09Is CTVA or FMC better for a retirement portfolio?
For long-horizon retirement investors, Corteva, Inc.
(CTVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 9% yield, +195. 9% 10Y return). FMC Corporation (FMC) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CTVA: +195. 9%, FMC: -26. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CTVA and FMC?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CTVA is a mid-cap quality compounder stock; FMC is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.